BRYSON ONEIL: Open Payments
NPI 1114376852 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,665 in 284 payments from 22 companies in 2025. Trend: 2023 $3,200 · 2024 $4,999 · 2025 $20,665
Speaker / faculty: $15,150Food & beverage: $5,351Education: $164
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 59 | $16,515 |
| Janssen Biotech, Inc. | 44 | $832 |
| ABBVIE INC. | 33 | $553 |
| Arcutis Biotherapeutics, Inc. | 36 | $483 |
| UCB, Inc. | 16 | $402 |
| Incyte Corporation | 12 | $307 |
| Regeneron Healthcare Solutions, Inc. | 13 | $274 |
| PFIZER INC. | 10 | $198 |
| Novartis Pharmaceuticals Corporation | 8 | $180 |
| GENZYME CORPORATION | 8 | $144 |
Products named: NEMLUVIO, TREMFYA, Zoryve, Bimzelx, DUPIXENT, OPZELURA, RINVOQ, SKYRIZI.
Industry payments across TX — which companies pay providers there.
